Teva Pharmaceutical (Israel) Investor Sentiment

TEVA Stock  ILA 5,977  64.00  1.06%   
About 61% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
  
over three months ago at news.google.com         
Teva Pharmaceutical Industries Limited is largely controlled by institutional shareholders who own 6...
Google News at Macroaxis
over three months ago at news.google.com         
Technical Data - Stock Traders Daily
Google News at Macroaxis
over three months ago at news.google.com         
Teva Pharmaceutical Industries Limited Shares Sold by Sumitomo Mitsui Trust Holdings Inc. - MarketBe...
Google News at Macroaxis
over three months ago at news.google.com         
Teva Pharmaceutical Industries Reaches New 12-Month High at 18.58 - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Teva Pharmaceutical Industries Limited Receives 18.67 Consensus Price Target from Analysts - MarketB...
Google News at Macroaxis
over three months ago at news.google.com         
TEVA EBITDA per Share 1.69 - GuruFocus.com
Google News at Macroaxis
over three months ago at news.google.com         
Bokf Na Lowers Position in Teva Pharmaceutical Industries Limited - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
American International Group Inc. Has 2.49 Million Position in Teva Pharmaceutical Industries Limite...
Google News at Macroaxis
over three months ago at news.google.com         
Zacks Research Equities Analysts Boost Earnings Estimates for Teva Pharmaceutical Industries Limited...
Google News at Macroaxis
over three months ago at news.google.com         
My Doctor Might Prescribe Teva, but Would I Prescribe the Stock - TheStreet
Google News at Macroaxis
over three months ago at news.google.com         
QRG Capital Management Inc. Acquires 50,247 Shares of Teva Pharmaceutical Industries Limited - Marke...
Google News at Macroaxis
over three months ago at news.google.com         
Is Teva Pharmaceutical Industries A Risky Investment - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Teva Pharmaceuticals Stock Unlock Value in This Generic Drug Gem - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Diversify Advisory Services LLC Takes Position in Teva Pharmaceutical Industries Limited - Defense W...
Google News at Macroaxis
over three months ago at news.google.com         
17575 Shares in Teva Pharmaceutical Industries Limited Bought by Park Avenue Securities LLC - Defens...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bonds Directory
Find actively traded corporate debentures issued by US companies